Endoscopic Mucosal Resection (EMR) Device Market Size, Production, Sales, Average Product Price, Market Share, Import vs Export 

Rising Prevalence of GI Disorders Driving Growth in the Endoscopic Mucosal Resection (EMR) Device Market 

The Endoscopic Mucosal Resection (EMR) Device Market is witnessing robust growth fueled by the escalating incidence of gastrointestinal (GI) disorders, including colorectal and esophageal cancers. For instance, with colorectal cancer ranking as the third most commonly diagnosed cancer globally, the demand for early detection and minimally invasive treatment solutions continues to rise. EMR procedures, being both preventive and therapeutic, are gaining significant traction. According to Datavagyanik, the incidence rate of early-stage GI cancers has shown a 12–15% year-over-year increase in high-income countries, driving hospitals and specialty clinics to adopt EMR devices more aggressively. 

Endoscopic Mucosal Resection (EMR) Device Market

Technological Advancements Enhancing Precision in the Endoscopic Mucosal Resection (EMR) Device Market 

One of the most dynamic trends shaping the Endoscopic Mucosal Resection (EMR) Device Market is the rapid technological innovation in EMR tools. Devices with enhanced visualization, electrosurgical capabilities, and integrated injection needles are enabling practitioners to perform more accurate resections with minimized complications. For instance, the adoption of hybrid-knife technology and water-jet EMR systems has improved outcomes in complex cases. Datavagyanik reports a 28% rise in the procurement of such advanced devices by leading endoscopy centers between 2022 and 2024, reflecting the increasing preference for devices that combine safety, speed, and precision. 

Shift Toward Minimally Invasive Procedures Elevating the Endoscopic Mucosal Resection (EMR) Device Market 

The paradigm shift toward minimally invasive procedures is significantly amplifying demand across the Endoscopic Mucosal Resection (EMR) Device Market. Patients and providers alike are opting for procedures that reduce hospital stays, lower recovery times, and carry fewer risks of post-operative complications. EMR procedures meet all these criteria and are increasingly preferred over conventional surgical resections. For example, outpatient EMR procedures have increased by over 35% globally in the last five years, signaling a clear market preference for less invasive treatment modalities. This trend is anticipated to continue, especially as healthcare systems aim to optimize cost-efficiency without compromising clinical outcomes. 

Aging Population Contributing to Expansion in the Endoscopic Mucosal Resection (EMR) Device Market 

The global aging demographic is directly contributing to the expansion of the Endoscopic Mucosal Resection (EMR) Device Market. Individuals aged 60 and above are more prone to gastrointestinal polyps and mucosal abnormalities, which are prime indications for EMR. For instance, in Japan—where over 28% of the population is aged 65 or older—the number of EMR procedures per 100,000 people has nearly doubled in the past decade. This geriatric-driven surge in EMR applications has led to increased investments in high-volume endoscopy units and a corresponding uptick in EMR device sales. 

Rising Adoption in Emerging Markets Fueling the Endoscopic Mucosal Resection (EMR) Device Market 

Emerging economies across Asia-Pacific and Latin America are becoming significant contributors to the Endoscopic Mucosal Resection (EMR) Device Market. With expanding healthcare infrastructure, increased public awareness, and rising incidences of GI cancers in these regions, the market is registering unprecedented growth. For example, India has seen a 22% annual increase in diagnostic endoscopies over the past three years. As a result, the EMR device market in the region is projected to grow at a CAGR of over 11% through 2030, according to Datavagyanik. Regional manufacturers are also entering the landscape, creating affordable alternatives that are boosting procedure volumes in cost-sensitive markets. 

Hospital Sector Dominance in the Endoscopic Mucosal Resection (EMR) Device Market 

Hospitals continue to dominate the Endoscopic Mucosal Resection (EMR) Device Market, accounting for the largest share in terms of both volume and value. The integration of EMR into comprehensive cancer screening programs, combined with reimbursement support and access to advanced technologies, makes hospitals the primary centers for EMR adoption. For instance, large tertiary hospitals in the United States and Germany are performing over 70% of all EMR procedures conducted nationally. This trend reinforces the centrality of hospital-based systems in market growth, even as outpatient surgical centers begin to gain ground. 

Integration of AI and Imaging Boosting the Endoscopic Mucosal Resection (EMR) Device Market 

Artificial intelligence (AI) and enhanced imaging technologies are transforming the Endoscopic Mucosal Resection (EMR) Device Market by enabling early and more accurate detection of mucosal abnormalities. For example, AI-based polyp detection systems integrated into EMR-compatible endoscopes have improved diagnostic accuracy by over 20%. These innovations are enhancing clinical decision-making, reducing the rate of missed lesions, and increasing the procedural success rate. Datavagyanik notes that AI-enabled EMR procedures are growing at nearly double the rate of conventional ones, underscoring a future in which precision and automation redefine endoscopic intervention. 

Outpatient Clinics Emerging as Key End-Users in the Endoscopic Mucosal Resection (EMR) Device Market 

While hospitals dominate, outpatient clinics are rapidly emerging as pivotal stakeholders in the Endoscopic Mucosal Resection (EMR) Device Market. These clinics offer cost-effective and convenient care options for patients with low-risk lesions, particularly in urban areas with dense populations. For instance, in countries like South Korea and Australia, outpatient EMR clinics have seen a 40% increase in patient inflow since 2021. This rise is driving investments in compact, portable EMR systems tailored to non-hospital environments, adding a new layer of competition and opportunity within the market. 

Reimbursement Policy Changes Reshaping the Endoscopic Mucosal Resection (EMR) Device Market 

Changes in reimbursement frameworks are playing a pivotal role in shaping the Endoscopic Mucosal Resection (EMR) Device Market. Countries that have included EMR under public or insurance-funded healthcare systems have seen faster adoption. For example, after EMR was added to Medicare coverage in the United States, procedure volumes surged by 18% in the following fiscal year. Similarly, new procedural codes and reimbursement brackets in EU nations have encouraged broader EMR implementation across both public and private institutions. These financial enablers are crucial in unlocking market potential, particularly in middle-income countries. 

Endoscopic Mucosal Resection (EMR) Device Market Size Reflecting Significant Uptrend 

The Endoscopic Mucosal Resection (EMR) Device Market Size has been expanding steadily, reflecting the growing demand across healthcare systems globally. Datavagyanik estimates place the global market value at over USD 1.3 billion in 2024, with projections suggesting a compound annual growth rate exceeding 9% through 2030. Much of this expansion is being fueled by heightened screening initiatives, especially for colorectal and esophageal cancers, as well as technological enhancements that are expanding the indications for EMR use. The surge in device installations across ambulatory surgical centers is another key contributor to the increasing Endoscopic Mucosal Resection (EMR) Device Market Size. 

Training and Skill Development Elevating the Endoscopic Mucosal Resection (EMR) Device Market 

Another essential factor driving the Endoscopic Mucosal Resection (EMR) Device Market is the expansion of specialized training programs for gastroenterologists and endoscopy technicians. Advanced skill acquisition is critical for the safe and effective use of EMR devices, particularly in complex polyp removal cases. For instance, leading medical institutions have reported a 30% increase in EMR-related training enrollments over the past two years. This growing talent pool is not only enhancing procedural success rates but also encouraging the broader adoption of EMR technology in both developed and emerging markets. 

Conclusion: Endoscopic Mucosal Resection (EMR) Device Market Poised for Continued Acceleration 

The overall trajectory of the Endoscopic Mucosal Resection (EMR) Device Market reflects a confluence of strong clinical demand, technological evolution, favorable policy environments, and expanding global healthcare infrastructure. From rising GI disease prevalence to the increasing reliance on outpatient and AI-integrated procedures, the market is being driven by multidimensional forces. With the Endoscopic Mucosal Resection (EMR) Device Market Size set for significant growth and new geographies entering the fold, stakeholders across the value chain—from manufacturers to healthcare providers—are poised to benefit from this wave of innovation and expansion. 

 

“Track Country-wise Endoscopic Mucosal Resection (EMR) Device Production and Demand through our Database”

      • Endoscopic Mucosal Resection (EMR) Device sales volume database for 27+ countries worldwide

Strong Regional Demand Trends Shaping the Endoscopic Mucosal Resection (EMR) Device Market 

The Endoscopic Mucosal Resection (EMR) Device Market demonstrates sharply contrasting regional growth dynamics. North America continues to lead in terms of market share, driven by high procedural volumes, robust reimbursement frameworks, and widespread access to advanced endoscopy suites. For instance, the United States alone accounted for over 35% of the global EMR device consumption in 2024, with more than 900,000 EMR procedures performed. This dominance is largely attributed to aggressive colorectal cancer screening programs and a strong base of GI-specialist physicians. 

In contrast, Europe follows closely with consistent year-on-year growth. Countries like Germany, France, and the United Kingdom have shown a combined annual increase of 10–12% in EMR device usage. For example, the introduction of population-based colorectal cancer screening in Germany has directly correlated with a 16% rise in EMR procedures between 2021 and 2024. Hospitals across the EU are aligning with WHO’s early detection mandates, further increasing demand for high-quality EMR systems. 

Asia-Pacific is emerging as the fastest-growing region in the Endoscopic Mucosal Resection (EMR) Device Market. For instance, Japan has long been a front-runner in endoscopic innovation, with over 400,000 EMR procedures performed annually, often supported by public health insurance. In China, growth is being fueled by rising GI disease prevalence and government-led health infrastructure upgrades. Datavagyanik highlights that EMR device adoption in China has increased at a CAGR of over 14% since 2020, with localized clinical training and indigenous manufacturing improving access across Tier II and III cities. 

Endoscopic Mucosal Resection (EMR) Device Manufacturing Gaining Global Diversification 

The landscape of Endoscopic Mucosal Resection (EMR) Device Manufacturing is undergoing significant diversification. Traditionally centered in the United States, Japan, and Germany, the manufacturing base is now expanding to include cost-competitive hubs like South Korea, India, and Brazil. This shift is primarily being driven by rising global demand and the strategic goal of regional self-reliance. 

For example, South Korean manufacturers have scaled up production capacities of injection needles and snare systems used in EMR, contributing to a 23% reduction in regional import dependency since 2021. India, leveraging its well-established medical device manufacturing ecosystem, is beginning to produce low-cost EMR kits tailored for public hospitals and primary health centers. Datavagyanik notes that Endoscopic Mucosal Resection (EMR) Device Manufacturing in India grew by over 18% year-over-year in 2023 alone, signaling the country’s emergence as a secondary manufacturing hub. 

This global expansion is also promoting competitive pricing, reduced lead times, and faster customization, thereby supporting the broader adoption of EMR technology in underpenetrated regions. 

Segmentation by Product Type Defining New Avenues in the Endoscopic Mucosal Resection (EMR) Device Market 

The Endoscopic Mucosal Resection (EMR) Device Market is highly segmented by product type, with distinct growth patterns across device categories. The primary components include snares, injection agents, retrieval devices, electrosurgical knives, and accessories such as hemostatic clips and endoscopic caps. 

Among these, EMR snares remain the most consumed product segment, contributing nearly 40% of total market revenue in 2024. For example, the growing number of early-stage polyp removal procedures using hot and cold snare techniques is reinforcing this trend. Injection agents, often prefilled with saline or dyes, represent the second-largest segment. Datavagyanik reports a 15% annual growth in usage of injectable submucosal lifting agents in the last three years, particularly in high-volume cancer centers. 

Retrieval devices and electrosurgical knives are registering double-digit growth rates as procedures become more complex. For instance, dual-function knives combining coagulation and incision capabilities are reducing the need for multiple instruments per procedure, thereby gaining favor among surgeons seeking workflow efficiency. 

Segmentation by End-User Expanding Application Scope in the Endoscopic Mucosal Resection (EMR) Device Market 

Endoscopic Mucosal Resection (EMR) Device Market segmentation by end-user reveals expanding demand across both institutional and non-institutional healthcare settings. Hospitals continue to dominate, representing over 60% of global device usage due to their infrastructure, physician availability, and integration of EMR in GI cancer pathways. 

Outpatient surgical centers and specialty GI clinics, however, are witnessing explosive growth. For instance, the number of EMR procedures performed in ambulatory care centers in the United States increased by 27% between 2021 and 2024. These centers are leveraging compact, portable EMR systems that offer cost-effective and quick-turnaround services, especially for low-risk cases. 

Additionally, academic and research institutions represent a niche yet growing segment. They are increasingly involved in training and piloting new EMR technologies, thereby creating early demand for next-generation devices such as AI-enabled scopes and hybrid dissection tools. 

Geographic Manufacturing Expansion Enhancing Supply Chain Resilience in the Endoscopic Mucosal Resection (EMR) Device Market 

The transformation of the Endoscopic Mucosal Resection (EMR) Device Manufacturing landscape is also bolstering global supply chain resilience. As manufacturers establish regional facilities in Latin America, Southeast Asia, and Eastern Europe, dependency on traditional hubs is being reduced. 

For instance, Brazilian-based medical technology firms have started assembling EMR kits locally under government-backed healthcare technology transfer programs. This has resulted in a 30% reduction in delivery timelines and up to 18% cost savings for regional buyers. Datavagyanik emphasizes that this localization trend in Endoscopic Mucosal Resection (EMR) Device Manufacturing is set to reshape procurement strategies, especially in public-sector hospitals facing budget constraints. 

Furthermore, OEM partnerships are enabling smaller firms in countries like Vietnam and Poland to enter the manufacturing value chain, promoting scalability and faster innovation cycles. 

Pricing Dynamics in the Endoscopic Mucosal Resection (EMR) Device Market Reflecting Regional Disparities 

The Endoscopic Mucosal Resection (EMR) Device Market exhibits notable regional price disparities influenced by manufacturing costs, regulatory environments, and supply-demand balance. For example, in high-income countries such as the United States and Japan, EMR devices are priced significantly higher due to stringent compliance standards, superior build quality, and strong brand preference. Premium EMR snares and injectables can cost up to 30% more in these regions compared to their counterparts in Southeast Asia or Latin America. 

In contrast, emerging markets are witnessing downward pricing pressure as domestic manufacturers introduce affordable alternatives. For instance, Indian-made EMR kits are priced nearly 40% lower than imported versions, helping increase procedure accessibility in rural and Tier II city hospitals. Datavagyanik points out that this cost advantage is driving volume growth in previously underserved markets without significantly compromising procedural efficacy. 

Bulk procurement models and price-volume contracts are also becoming common in Europe, where national healthcare systems negotiate device pricing for public hospitals. These efforts are contributing to more predictable pricing structures and supporting sustainable long-term market growth. 

Endoscopic Mucosal Resection (EMR) Device Market Growth Driven by Customization and Innovation in Manufacturing 

Customization is becoming a major differentiator in the Endoscopic Mucosal Resection (EMR) Device Manufacturing segment. Hospitals and surgical centers are increasingly requesting tailored device kits based on procedure type, patient demographics, and physician preferences. For example, pediatric EMR kits with smaller gauge needles and gentler snare mechanisms are now being developed in response to rising early-age GI polyp detection. 

Additionally, innovation in materials—such as the use of memory-shape alloys and ultra-flexible sheaths—is further driving the evolution of EMR devices. These advancements are particularly important in complex anatomical regions like the duodenum or esophagus, where precision and maneuverability are critical. Datavagyanik highlights that the ability to manufacture such specialized devices is becoming a core competency for leading manufacturers and is expected to drive above-average growth in the premium segment of the Endoscopic Mucosal Resection (EMR) Device Market. 

Conclusion: Endoscopic Mucosal Resection (EMR) Device Market at the Crossroads of Global Demand and Local Innovation 

The Endoscopic Mucosal Resection (EMR) Device Market is positioned at the intersection of escalating global demand and expanding localized innovation. While advanced economies drive premium device consumption, emerging regions are pushing volume through affordable, domestically manufactured solutions. Simultaneously, the evolution of Endoscopic Mucosal Resection (EMR) Device Manufacturing across multiple geographies is enhancing cost efficiency, accelerating product development, and improving access to life-saving GI procedures. With strong segmentation across product types and end-user categories, coupled with dynamic pricing and supply chain strategies, the market is expected to maintain an aggressive growth trajectory over the coming years. 

“Endoscopic Mucosal Resection (EMR) Device Manufacturing Database”

      • Endoscopic Mucosal Resection (EMR) Device top manufacturers market share for 27+ manufacturers
      • Top 7 manufacturers and top 17 manufacturers of Endoscopic Mucosal Resection (EMR) Device in North America, Europe, Asia Pacific
      • Endoscopic Mucosal Resection (EMR) Device sales dashboard, Endoscopic Mucosal Resection (EMR) Device sales data in excel format

Top Manufacturers Dominating the Endoscopic Mucosal Resection (EMR) Device Market 

The Endoscopic Mucosal Resection (EMR) Device Market is led by a concentrated group of globally recognized manufacturers that command significant market share. These include Olympus, Boston Scientific, CONMED, Cook Medical, and ERBE Elektromedizin. Collectively, these companies account for approximately 60 to 65 percent of the total market. Each manufacturer brings a unique focus, whether in visualization technology, electrosurgical innovation, or integrated EMR solutions, which shapes the competitive dynamics of the market. 

CONMED: Expanding Presence Through Electrosurgical EMR Tools 

CONMED has established itself as a key player in the Endoscopic Mucosal Resection (EMR) Device Market, particularly through its advanced snare and electrosurgical product lines. The company’s DualCut snares, which combine hot and cold resection functions, have gained rapid acceptance in surgical centers seeking versatility and procedural efficiency. With distribution across more than 30 countries and growing procedural adoption, CONMED currently holds an estimated global market share of 12 to 14 percent. 

Boston Scientific: Leader in Hybrid Tissue Resection Platforms 

Boston Scientific continues to reinforce its leadership in the Endoscopic Mucosal Resection (EMR) Device Market through innovation in hybrid resection platforms. Its ResectRx product line is designed to integrate cutting and coagulation in one device, reducing the number of tools required per procedure. These devices have been widely adopted in tertiary care institutions performing high volumes of GI resections. Boston Scientific is estimated to maintain a 14 to 16 percent share in the global EMR device market, driven by its strong product performance and surgeon loyalty. 

Cook Medical: Simplifying Procedures with Disposable EMR Kits 

Cook Medical holds a notable share in the Endoscopic Mucosal Resection (EMR) Device Market, driven by its focus on simplified, all-in-one disposable EMR kits. Its SoloCapture product, developed for single-use efficiency, has found traction in ambulatory surgical centers where speed and infection control are priorities. With expanding adoption in the United States and Europe, Cook Medical’s market share is estimated at around 10 to 12 percent. 

Olympus: Dominance in Visualization and Integrated EMR Solutions 

Olympus is widely considered a global leader in endoscopic visualization and has extended this dominance into the Endoscopic Mucosal Resection (EMR) Device Market. Its VISERA platform and AI-based tools for mucosal detection have positioned Olympus at the forefront of technologically advanced EMR solutions. The company’s broad product portfolio and extensive clinical reach contribute to its estimated 18 to 20 percent share in the global EMR device market. 

ERBE and STERIS: Focus on Electrosurgical Innovation 

ERBE Elektromedizin, along with STERIS, holds a combined 8 to 10 percent market share in the Endoscopic Mucosal Resection (EMR) Device Market. ERBE’s VIO electrosurgical generator system has been widely integrated with EMR-compatible snares, especially in Europe. STERIS, while more niche, has focused on packaging energy-based tools with customizable accessories for hospital settings. 

Market Share Overview by Manufacturer 

The Endoscopic Mucosal Resection (EMR) Device Market is characterized by a mix of large players and smaller regional manufacturers. Olympus, Boston Scientific, CONMED, Cook Medical, and ERBE dominate the top tiers, while others such as Karl Storz, Interscope, Sumitomo, and emerging Asian manufacturers contribute to the remaining 30 percent. These smaller players often focus on regional or specialized markets, offering either cost-competitive or highly specialized EMR solutions. 

Product Portfolios Supporting Market Leadership 

Olympus has strengthened its leadership through its VISERA Elite III visualization system and AI-enhanced mucosal detection tools. Boston Scientific’s ResectRx Hybrid Knife has improved procedural efficiency in advanced EMR applications. CONMED’s DualCut snares offer dual-modality functionality that appeals to centers with high procedural variability. Cook Medical’s SoloCapture disposable kits are purpose-built for outpatient environments where time and infection control are critical. ERBE’s VIO electrosurgical platforms remain integral in hospitals seeking customizable energy-based resection capabilities. 

These differentiated product lines support diversified growth strategies among top players and have allowed each manufacturer to penetrate specific segments within the broader Endoscopic Mucosal Resection (EMR) Device Market. 

Recent Developments Among Key Players in the Endoscopic Mucosal Resection (EMR) Device Market 

In the past two years, several notable developments have shaped the competitive landscape of the Endoscopic Mucosal Resection (EMR) Device Market. 

In May 2025, Olympus introduced a next-generation EMR platform with integrated cloud-based analytics, enabling remote monitoring of mucosal resections and enhancing real-time procedural decision-making. This development marked a significant leap in AI-assisted endoscopic procedures. 

In early 2023, CONMED announced an expanded R&D pipeline focused on dual-modality EMR devices, which are expected to launch across North America and Europe by 2026. These devices are designed to reduce procedural steps and minimize thermal damage during resection. 

Cook Medical obtained regulatory clearance for its SoloCapture EMR kit in late 2022, with distribution expanded to more than 20 countries by mid-2024. This disposable kit is designed to integrate snaring, lifting, and retrieval into one streamlined system. 

Boston Scientific made strategic moves in 2023, acquiring a start-up focused on real-time endoscopic analytics, a step that aligns with its strategy to enhance the intelligence and automation capabilities of its EMR product lines. 

Also in 2024, ERBE launched a new version of its electrosurgical platform, offering improved energy modulation for use in both EMR and ESD procedures. This upgrade was quickly adopted in teaching hospitals and training centers across Europe. 

 

“Endoscopic Mucosal Resection (EMR) Device Production Data and Endoscopic Mucosal Resection (EMR) Device Production Trend”

      • Endoscopic Mucosal Resection (EMR) Device sales database for historical years, 10 years historical data
      • Endoscopic Mucosal Resection (EMR) Device sales data and forecast for next 7 years

 

Key Insights that the Endoscopic Mucosal Resection (EMR) Device Market analysis report presents are:

  • Endoscopic Mucosal Resection (EMR) Device Market revenue and demand by countries
  • Endoscopic Mucosal Resection (EMR) Device Market production and sales volume by countries
  • Break-down of the Endoscopic Mucosal Resection (EMR) Device Market in terms of application areas, target customers and other potential market segments
  • Areas that are relatively more potential and are faster growing
  • Endoscopic Mucosal Resection (EMR) Device Market competitive scenario, market share analysis
  • Endoscopic Mucosal Resection (EMR) Device Market business opportunity analysis

 

 

Global and Country-Wise Endoscopic Mucosal Resection (EMR) Device Market Statistics

  • Global and Country-Wise Endoscopic Mucosal Resection (EMR) Device Market size ($Million) and Forecast – (2021 – 2028)
  • Global and Country-Wise Endoscopic Mucosal Resection (EMR) Device Market Production Volume and Forecast – (2021 – 2028)
  • Global and Country-Wise Endoscopic Mucosal Resection (EMR) Device Market Sales Volume and Forecast – (2021 – 2028)
  • Global and Country-Wise Endoscopic Mucosal Resection (EMR) Device Market Business Opportunity Assessment

“Every Organization is different and so are their requirements”- Datavagyanik

Companies We Work With

Do You Want To Boost Your Business?

drop us a line and keep in touch

Shopping Cart

Request a Detailed TOC

Add the power of Impeccable research,  become a DV client

Contact Info

Talk To Analyst

Add the power of Impeccable research,  become a DV client

Contact Info